Clinical Research Directory
Browse clinical research sites, groups, and studies.
Chloroprocaine 1% Versus Ropivacaine 0,75% During Cesarean Section
Sponsor: Aretaieion University Hospital
Summary
This will be a prospective randomized study, aiming at comparing an intrathecal fixed dose of chloroprocaine 1% versus an intrathecal fixed dose of ropivacaine 0.75% in elective cesarean sections
Official title: Intrathecal Use of Chloroprocaine 1% and Ropivacaine 0,75% During Elective Cesarean Section. A Comparative Study
Key Details
Gender
FEMALE
Age Range
18 Years - 48 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2024-01-10
Completion Date
2026-01-10
Last Updated
2025-07-22
Healthy Volunteers
No
Conditions
Interventions
Chloroprocaine 1% Injectable Solution
• in parturients allocated to the chloroprocaine group, a fixed dose of chloroprocaine 1% will be administered intrathecally
Ropivacaine 0.75% Injectable Solution
• in parturients allocated to the ropivacaine group, a fixed dose of ropivacaine 0.75% will be administered intrathecally
Locations (1)
Aretaieion University Hospital
Athens, Greece